IWA
CTIC

Intercontinental Wealth Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Intercontinental Wealth Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14
Closed – – 334
2019
Q4 		$0 Hold
14
– – ﹤0.01% 438
2019
Q3 		$0 Hold
14
– – ﹤0.01% 452
2019
Q2 		$0 Hold
14
– – ﹤0.01% 445
2019
Q1 		$0 Hold
14
– – ﹤0.01% 467
2018
Q4 		$0 Buy
+14
New +$23 ﹤0.01% 456

Other funds holding CTIC

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Intercontinental Wealth Advisors's CTIC Position: Q1 2020 in Review

Intercontinental Wealth Advisors sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q1 2020, closing a stake of 14 shares.

Intercontinental Wealth Advisors first reported a position in CTIC in Q4 2018 and held it in 5 quarters. The position peaked at $0 in Q4 2019. 38 funds tracked by Wall St. Rank hold CTIC as of Q1 2020.

  • Intercontinental Wealth Advisors reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q1 2020 after selling out during the quarter.
  • Intercontinental Wealth Advisors sold 14 CTI BioPharma Corp. (DE) Common Stock shares in Q1 2020.
  • Intercontinental Wealth Advisors first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2018 and held it in 5 quarters.
  • Intercontinental Wealth Advisors's CTI BioPharma Corp. (DE) Common Stock position peaked at $0 in Q4 2019.
  • 38 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2020.

Based on Intercontinental Wealth Advisors's 13F filing for Q1 2020, filed 19 Jan 2021.